Pneumothorax Incidence in Patients With Chronic Lung Comorbidities Receiving Continuous Positive Airway Pressure and Noninvasive Ventilation: A Retrospective Observational Study in a District General Hospital
Year: 2026
Type: article
Study design: Observational Study
Abstract: Introduction Continuous positive airway pressure (CPAP) and non-invasive ventilation (NIV) are widely used in acute and chronic respiratory failure. CPAP is commonly used for obstructive sleep apnea-hypopnea syndrome, while NIV has an established role in acute hypercapnic respiratory failure and selected patients with chronic ventilatory failure. Many patients have underlying chronic lung disease, potentially increasing the risk of barotrauma and pneumothorax. Real-world data on pneumothorax incidence among these patients remain poorly described. We aimed to describe the occurrence of documented pneumothorax and explore its association with chronic respiratory comorbidities. Materials and methods We conducted a retrospective observational study of 306 adults manually selected at random from patients receiving CPAP or NIV between May 2023 and May 2025 across outpatient, inpatient, and emergency settings at Blackpool Victoria Hospital, Blackpool, United Kingdom. Clinical records and available chest imaging were reviewed for documented pneumothorax and respiratory comorbidities (chronic obstructive pulmonary disease (COPD), bronchiectasis, and interstitial lung disease (ILD)). Follow-up imaging was not systematic. Smoking history was recorded separately. Descriptive statistics, exact 95% confidence intervals (CIs), and two-sided Fisher's exact tests were used. The study received institutional clinical audit approval, and all analysed data were de-identified. Results A total of 306 patients were included. Pneumothorax was documented in two patients following CPAP/NIV initiation, representing 0.7% (2/306; 95% exact binomial CI: 0.1%-2.3%). Overall, 203 patients (66.3%) had at least one respiratory comorbidity, including COPD in 60 (19.6%), bronchiectasis in 17 (5.6%), ILD in 16 (5.2%), and other comorbidities in 118 (38.6%). Smoking history was recorded separately in 67 patients (21.9%). Both patients with pneumothorax had underlying chronic respiratory disease: one had COPD, and the other had ILD. No statistically significant association was observed for the presence of any respiratory comorbidity (p = 0.552), COPD (p = 0.354), or ILD (p = 0.102). Discussion Documented pneumothorax was uncommon in this heterogeneous CPAP/NIV cohort despite the high prevalence of respiratory comorbidities. However, non-systematic follow-up imaging may have led to underestimation of its occurrence. With only two events, associations with individual comorbidities could not be reliably assessed. These findings provide descriptive real-world evidence but do not establish the safety of CPAP/NIV or exclude increased pneumothorax risk in patients with chronic lung disease. Conclusions Documented pneumothorax was uncommon among patients receiving CPAP/NIV, despite a high prevalence of respiratory comorbidities. However, the small number of events and non-systematic follow-up imaging limit conclusions regarding its true occurrence and associated risk factors. Further studies with systematic monitoring and larger populations are needed to better assess pneumothorax risk in these patients.
Source: Cureus
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: pneumothorax, continuous positive airway pressure, non-invasive ventilation, chronic lung disease, chronic obstructive pulmonary disease, interstitial lung disease, bronchiectasis, barotrauma, smoking, respiratory comorbidities, hypercapnic respiratory failure, obstructive sleep apnea-hypopnea syndrome, chronic ventilatory failure, acute respiratory failure
Open Access status: diamond
OpenAlex ID: W7236750455
